Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
US FDA Observation
|
Mid-range Performer
1043.9000
3.70
(
0.36
%)
NSE
Sep 09, 2025
15:51 PM
Near 52W Low of ₹1010.00
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
17 Nov 2023
US FDA Observation
1043.90
0.36%
AUROBINDO PHARMA LTD
Hold:
Aurobindo Pharma Ltd.
by
Geojit BNP Paribas
Target: 1037
Target
Geojit BNP Paribas
Aurobindo Pharma Ltd. has lost
-32.10%
in the last 1 Year
More from Aurobindo Pharma Ltd.
Recommended
Market closes higher, Alembic Pharma gets US FDA nod for Phytonadione injectable emulsion
Trendlyne Marketwatch |
09 Sep 2025, 04:00PM
IPOs this week: Seven upcoming listings, Urban Company plus ten new issues
|
08 Sep 2025, 05:30PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020